System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Amit Goel is an expert in Hepatology at Sanjay Gandhi Post Graduate Institute of Medical Sciences (India). As of October 2026, ScienceLeadR ranks Amit Goel in the top 1% of experts worldwide for Hepatitis. Amit Goel has authored 280 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 950 (community average: 125). How the SLR is computed.

LeadR Profile

Amit Goel Sanjay Gandhi Post Graduate Institute of Medical Sciences India
950 ScienceLeadR Reputation 950

Unlock

Register Login
Network Map

Hepatology

Subspecialties: Gastroenterology - Public Health - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2003 - 2026
Source: PubMed

Sanjay Gandhi Post Graduate Institute of Medical Sciences

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 280

Citations

Citations: 9 155 1st author: 49 Last author: 54 Unique author: 4

Main journals

J Clin Exp Hepatol 37
Indian J Gastroenterol 19
Lancet 9
Cardiol Res 8
J Gastroenterol Hepatol 8

Best Journals

Lancet 9
Lancet Gastroenterol Hepatol 2
J Hepatol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.
PMID 42815507 — hepatitis c, chronic, hepatitis c, pharmaceutical preparations, hepatitis, chronic, drug-related side effects and adverse reactions, sofosbuvir, therapeutics, infections, hepatitis		Lancet Top journal20260
Peripheral Neuropathy and Restless Legs Syndrome in Cirrhosis: An Electrophysiological Cross-sectional Study.
PMID 42756980 — cross-sectional studies, peripheral nervous system diseases, restless legs syndrome		J Clin Exp Hepatol20260
Mapping drivers of life expectancy change in Asia from 1990 to 2023.
PMID 42486974 — mortality, income, life expectancy, risk factors, pandemics		Nature Top journal20261
Rechristen 'Cardiovascular-Kidney-Metabolic (CKM)' health to 'Cardiovascular-Kidney-Liver-Metabolic (CKLM)' health: Bridge the Gap.
PMID 42232135 — kidney, liver		J Clin Exp Hepatol20260
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
PMID 42229499 — mortality, typhoid fever, rotavirus, global health, cause of death, global burden of disease, cost of illness, communicable diseases, child		Lancet Infect Dis20261

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 4
Phase 3 2
Phase 4 1

By status:

Completed 4
Recruiting 1
Terminated 1
Unknown 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction Associated Steatotic Liver Disease (SYNERGY Outcomes)
NCT07165028 — liver diseases, non-alcoholic fatty liver disease, liver, alcoholics, incretins, fatty liver, fatty liver, alcoholic		Phase 3Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS